Research and Markets has announced the addition of the "Cystic Fibrosis - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Cystic Fibrosis in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2022. Market data and analytics are derived from primary and secondary research.
The report profiles 56 companies, including many key and niche players such as:
Key Topics Covered:
1. Market Overview
2. Research In Cystic Fibrosis Space
3. Disease Overview
4. Cystic Fibrosis Treatment: An Overview
5. Clinical Studies
6. Product Launches/Approvals
7. Recent Industry Activity
8. Select Clinical-Stage Players
9. Focus On Select Global Players
10. Global Market Perspective
Total Companies Profiled: 56 (including Divisions/Subsidiaries 58)
- The United States (30)
- Canada (4)
- Europe (20)
- France (2)
- Germany (2)
- The United Kingdom (3)
- Italy (2)
- Rest of Europe (11)
- Asia-Pacific (Excluding Japan) (1)
- Middle East (3)
For more information about this report visit http://www.researchandmarkets.com/research/nzbg59/cystic_fibrosis.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170320006184/en/Business Wire
Last updated on: 20/03/2017
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.